Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 6, 2000

View Archived Issues

Increased bone formation associated with Fra-1 and deltaFosB overexpression in transgenic mice

Antileukemia immune response identified

Arimidex does not compromise subsequent treatment of breast cancer with tamoxifen

Vion and Memorial Sloan-Kettering present preclinical TAPET data

Dura acquires distribution rights for Glaxo Wellcome dermatology product line

BioSante's CAP vaccine adjuvant completes phase I clinical trial

Gene therapy trial for blocked coronary arteries commenced by Genzyme Surgical Products

NeoRx's skeletal targeted radiotherapy progresses to phase III

Phase III trial of Actimmune begins for treatment of idiopathic pulmonary fibrosis

Intranasal apomorphine phase I results reported

DTI-015 phase I/II clinical trials begin enrollment for treatment of glioblastoma multiforme

Promising phase I data reported for Enzo Biochem gene medicine

Lasofoxifene's bone protective effects tested in multiple studies

Bone strength, density improved by LY-353381 in ovariectomized rats

MCC-565 prevents bone loss due to estrogen deficiency in monkeys

Oral alphavbeta3 antagonist L-806978 inhibits bone loss in vivo

Novel tricyclic compounds from Dr. Reddy useful for hyperglycemia, hyperlipidemia, etc.

Kinase inhibitors and their use in the treatment of cancer, psoriasis and osteoporosis

R&D at Darwin Discovery leads to new group of PDE4/TNF inhibitors

Series of microtubule-stabilizing epothilone derivatives jointly developed by BMS and GBF

BioChem Pharma reveals novel compounds for hepatitis C virus

Dihydroquinazoline antitumor agents with folate-independent mechanism described by CRC

Potent topoisomerase inhibitors related to camptothecin described in recent patent

IC-351 effective and safe as once-daily or on-demand therapy for ED

HEP-187, a new vitamin D analogue with a promising profile for metabolic bone diseases

Zeldox reaches market first in Sweden

ASBMR news: potent new cathepsin K inhibitor from SB prevents bone loss in ovariectomized rats

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...